1
|
Silva FALS, Pinto S, Santos SG, Magalhães FD, Sarmento B, Pinto AM. New graphene-containing pharmaceutical formulations for infrared lamps-based phototherapy of skin cancer: In vitro validation and ex-vivo human skin permeation. NANOMEDICINE : NANOTECHNOLOGY, BIOLOGY, AND MEDICINE 2024; 57:102734. [PMID: 38295912 DOI: 10.1016/j.nano.2024.102734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/08/2024]
Abstract
Basal cell carcinoma (BCC) is the most common form of human cancer, and treatment usually involves surgery, with alternative strategies being needed. We propose the use of carbopol hydrogels (HG) for topical administration of nanographene oxide (GOn) and partially-reduced nanographene oxide (p-rGOn) for photothermal therapy (PTT) of BCC. GOn and p-rGOn incorporated into the HG present lateral sizes ∼200 nm, being stable for 8 months. After 20 min irradiation with an infrared (IR) photothermal therapy lamp (15.70 mW cm-2), GOn-HG increased temperature to 44.7 °C, while p-rGOn-HG reached 47.0 °C. Human skin fibroblasts (HFF-1) cultured with both hydrogels (250 μg mL-1) maintained their morphology and viability. After 20 min IR irradiation, p-rGOn HG (250 μg mL-1) completely eradicated skin cancer cells (A-431). Ex vivo human skin permeability tests showed that the materials can successfully achieve therapeutic concentrations (250 μg mL-1) inside the skin, in 2.0 h for GO HG or 0.5 h for p-rGOn HG.
Collapse
Affiliation(s)
- Filipa A L S Silva
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - Soraia Pinto
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal
| | - Susana G Santos
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - Fernão D Magalhães
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal
| | - Bruno Sarmento
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; CESPU-IUCS - Institute for Research and Advanced Training in Health Sciences and Technologies, Rua Central de Gandra 1317, 4585-116 Gandra, Portugal
| | - Artur M Pinto
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal.
| |
Collapse
|
2
|
Lin H, Buerki-Thurnherr T, Kaur J, Wick P, Pelin M, Tubaro A, Carniel FC, Tretiach M, Flahaut E, Iglesias D, Vázquez E, Cellot G, Ballerini L, Castagnola V, Benfenati F, Armirotti A, Sallustrau A, Taran F, Keck M, Bussy C, Vranic S, Kostarelos K, Connolly M, Navas JM, Mouchet F, Gauthier L, Baker J, Suarez-Merino B, Kanerva T, Prato M, Fadeel B, Bianco A. Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective. ACS NANO 2024; 18:6038-6094. [PMID: 38350010 PMCID: PMC10906101 DOI: 10.1021/acsnano.3c09699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/15/2024]
Abstract
Two-dimensional (2D) materials have attracted tremendous interest ever since the isolation of atomically thin sheets of graphene in 2004 due to the specific and versatile properties of these materials. However, the increasing production and use of 2D materials necessitate a thorough evaluation of the potential impact on human health and the environment. Furthermore, harmonized test protocols are needed with which to assess the safety of 2D materials. The Graphene Flagship project (2013-2023), funded by the European Commission, addressed the identification of the possible hazard of graphene-based materials as well as emerging 2D materials including transition metal dichalcogenides, hexagonal boron nitride, and others. Additionally, so-called green chemistry approaches were explored to achieve the goal of a safe and sustainable production and use of this fascinating family of nanomaterials. The present review provides a compact survey of the findings and the lessons learned in the Graphene Flagship.
Collapse
Affiliation(s)
- Hazel Lin
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| | - Tina Buerki-Thurnherr
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Jasreen Kaur
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Peter Wick
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Aurelia Tubaro
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | | | - Mauro Tretiach
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Emmanuel Flahaut
- CIRIMAT,
Université de Toulouse, CNRS, INPT,
UPS, 31062 Toulouse CEDEX 9, France
| | - Daniel Iglesias
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Ester Vázquez
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Giada Cellot
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Laura Ballerini
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Valentina Castagnola
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Fabio Benfenati
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Andrea Armirotti
- Analytical
Chemistry Facility, Istituto Italiano di
Tecnologia, 16163 Genoa, Italy
| | - Antoine Sallustrau
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Frédéric Taran
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Mathilde Keck
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Sandra Vranic
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Mona Connolly
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - José Maria Navas
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - Florence Mouchet
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - Laury Gauthier
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - James Baker
- TEMAS Solutions GmbH, 5212 Hausen, Switzerland
| | | | - Tomi Kanerva
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maurizio Prato
- Center
for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia-San
Sebastián, Spain
- Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain
- Department
of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy
| | - Bengt Fadeel
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Alberto Bianco
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| |
Collapse
|
3
|
Silva FALS, Timochenco L, Costa-Almeida R, Fernandes JR, Santos SG, Magalhães FD, Pinto AM. UV-C driven reduction of nanographene oxide opens path for new applications in phototherapy. Colloids Surf B Biointerfaces 2024; 233:113594. [PMID: 37979484 DOI: 10.1016/j.colsurfb.2023.113594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 10/03/2023] [Accepted: 10/11/2023] [Indexed: 11/20/2023]
Abstract
The main challenges associated to the application of graphene-based materials (GBM) in phototherapy are obtaining particles with lateral nanoscale dimensions and water stability that present high near-infrared (NIR) absorption. Nanosized graphene oxide (GOn) is stable in aqueous dispersion, due to the oxygen functionalities on its surface, but possesses low photothermal efficiency in NIR region. GOn total reduction originates reduced nanographene oxide (rGOn) that presents high NIR absorption, but poor water stability. In this work, we produced a partially reduced nanographene oxide (p-rGOn) by GOn photoreduction using ultraviolet radiation (UV-C), yielding nanometric particles that preserve the original water stability, but acquire high light-to-heat conversion efficiency. GOn and p-rGOn presented mean particle sizes of 170 ± 81 nm and 188 ± 99 nm, respectively. 8 h of UV-C irradiation allowed to obtain a p-rGOn stable for up 6 months in water, with a zeta potential of -32.3 ± 1.3 mV. p-rGOn water dispersions have shown to absorb NIR radiation, reaching 52.7 °C (250 µg mL-1) after 30 min NIR irradiation. Chemical characterization of p-rGOn showed a decrease in the number of characteristic oxygen functional groups, confirming GOn partial reduction. Furthermore, p-rGOn (250 µg mL-1) didn't cause any cytotoxicity (ISO10993-5:2009(E)) towards human skin fibroblasts (HFF-1) and human skin keratinocytes (HaCat), after 24 and 48 h incubation. An innovative custom-built NIR LED-system has been developed and validated for p-rGOn photothermal effect evaluation. Finally, exposure to p-rGOn+NIR-LEDs has caused no cytotoxicity towards HFF-1 or HaCat cells, revealing its potential to be used as a safe therapy.
Collapse
Affiliation(s)
- Filipa A L S Silva
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - Licínia Timochenco
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - Raquel Costa-Almeida
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - José Ramiro Fernandes
- CQVR - Centro de Química Vila Real, Universidade de Trás-os-Montes e Alto Douro, Portugal; Physical Department, University of Trás-os-Montes and Alto Douro, Quinta dos Prados, 5000-801 Vila Real, Portugal
| | - Susana G Santos
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal
| | - Fernão D Magalhães
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal
| | - Artur M Pinto
- LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, 4200-180 Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal.
| |
Collapse
|
4
|
Sosa S, Tubaro A, Carlin M, Ponti C, Vázquez E, Prato M, Pelin M. Assessment of skin sensitization properties of few-layer graphene and graphene oxide through the Local Lymph Node Assay (OECD TG 442B). NANOIMPACT 2023; 29:100448. [PMID: 36565921 DOI: 10.1016/j.impact.2022.100448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Revised: 11/25/2022] [Accepted: 12/16/2022] [Indexed: 06/17/2023]
Abstract
Skin contact is one of the most common exposure routes to graphene-based materials (GBMs) during their small-scale and industrial production or their use in technological applications. Nevertheless, toxic effects in humans by cutaneous exposure to GBMs remain largely unexplored, despite skin contact to other related materials has been associated with adverse effects. Hence, this in vivo study was carried out to evaluate the cutaneous effects of two GBMs, focusing on skin sensitization as a possible adverse outcome. Skin sensitization by few-layer graphene (FLG) and graphene oxide (GO) was evaluated following the Organization for Economic Cooperation and Development (OECD) guideline 442B (Local Lymph Node Assay; LLNA) measuring the proliferation of auricular lymph node cells during the induction phase of skin sensitization. Groups of four female CBA/JN mice (8-12 weeks) were daily exposed to FLG or GO through the dorsal skin of each ear (0.4-40 mg/mL, equal to 0.01-1.00 mg/ear) for 3 consecutive days, and proliferation of auricular lymph node cells was evaluated 3 days after the last treatment. During this period, no clinical signs of toxicity and no alterations in body weight and food or water consumptions were observed. In addition, no ear erythema or edema were recorded as signs of irritation or inflammation. Bromo-deoxyuridine (BrdU) incorporation in proliferating lymphocytes from ear lymph nodes (stimulation indexes <1.6) and the histological analysis of ear tissues excluded sensitizing or irritant properties of these materials, while myeloperoxidase activity in ear biopsies confirmed no inflammatory cells infiltrate. On the whole, this study indicates the absence of sensitization and irritant potential of FLG and GO.
Collapse
Affiliation(s)
- Silvio Sosa
- Department of Life Sciences, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
| | - Aurelia Tubaro
- Department of Life Sciences, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
| | - Michela Carlin
- Department of Life Sciences, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
| | - Cristina Ponti
- Department of Life Sciences, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
| | - Ester Vázquez
- Regional Institute of Applied Scientific Research (IRICA), University of Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain; Department of Organic Chemistry, Faculty of Science and Chemistry Technologies, University of Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Maurizio Prato
- Department of Chemical and Pharmaceutical Sciences, Via Giorgeri 1, University of Trieste, 34127 Trieste, Italy; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramon 182, 20014 Donostia San Sebastián, Spain; Basque Foundation for Science (IKERBASQUE), Plaza Euskadi 5, 48013 Bilbao, Spain
| | - Marco Pelin
- Department of Life Sciences, University of Trieste, Via Fleming 22, 34127 Trieste, Italy.
| |
Collapse
|
5
|
Toxicologic Concerns with Current Medical Nanoparticles. Int J Mol Sci 2022; 23:ijms23147597. [PMID: 35886945 PMCID: PMC9322368 DOI: 10.3390/ijms23147597] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2022] [Revised: 06/28/2022] [Accepted: 07/05/2022] [Indexed: 02/05/2023] Open
Abstract
Nanotechnology is one of the scientific advances in technology. Nanoparticles (NPs) are small materials ranging from 1 to 100 nm. When the shape of the supplied nanoparticles changes, the physiological response of the cells can be very different. Several characteristics of NPs such as the composition, surface chemistry, surface charge, and shape are also important parameters affecting the toxicity of nanomaterials. This review covered specific topics that address the effects of NPs on nanomedicine. Furthermore, mechanisms of different types of nanomaterial-induced cytotoxicities were described. The distributions of different NPs in organs and their adverse effects were also emphasized. This review provides insight into the scientific community interested in nano(bio)technology, nanomedicine, and nanotoxicology. The content may also be of interest to a broad range of scientists.
Collapse
|
6
|
Oliveira AML, Machado M, Silva GA, Bitoque DB, Tavares Ferreira J, Pinto LA, Ferreira Q. Graphene Oxide Thin Films with Drug Delivery Function. NANOMATERIALS 2022; 12:nano12071149. [PMID: 35407267 PMCID: PMC9000550 DOI: 10.3390/nano12071149] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Revised: 03/24/2022] [Accepted: 03/28/2022] [Indexed: 02/04/2023]
Abstract
Graphene oxide has been used in different fields of nanomedicine as a manager of drug delivery due to its inherent physical and chemical properties that allow its use in thin films with biomedical applications. Several studies demonstrated its efficacy in the control of the amount and the timely delivery of drugs when it is incorporated in multilayer films. It has been demonstrated that oxide graphene layers are able to work as drug delivery or just to delay consecutive drug dosage, allowing the operation of time-controlled systems. This review presents the latest research developments of biomedical applications using graphene oxide as the main component of a drug delivery system, with focus on the production and characterization of films, in vitro and in vivo assays, main applications of graphene oxide biomedical devices, and its biocompatibility properties.
Collapse
Affiliation(s)
- Alexandra M. L. Oliveira
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
- Correspondence: (A.M.L.O.); (Q.F.)
| | - Mónica Machado
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Gabriela A. Silva
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Diogo B. Bitoque
- iNOVA4Health, CEDOC Chronic Diseases Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, Portugal; (G.A.S.); (D.B.B.)
- NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
| | - Joana Tavares Ferreira
- Ophthalmology Department, Centro Hospitalar Universitário de Lisboa Norte, 1649-035 Lisbon, Portugal; (J.T.F.); (L.A.P.)
- Visual Sciences Study Centre, Faculty of Medicine, Universidade de Lisboa, 1649-028 Lisbon, Portugal
| | - Luís Abegão Pinto
- Ophthalmology Department, Centro Hospitalar Universitário de Lisboa Norte, 1649-035 Lisbon, Portugal; (J.T.F.); (L.A.P.)
- Visual Sciences Study Centre, Faculty of Medicine, Universidade de Lisboa, 1649-028 Lisbon, Portugal
| | - Quirina Ferreira
- Instituto de Telecomunicações, Avenida Rovisco Pais, 1049-001 Lisbon, Portugal;
- Correspondence: (A.M.L.O.); (Q.F.)
| |
Collapse
|
7
|
Gomes A, Aguiar L, Ferraz R, Teixeira C, Gomes P. The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years. Int J Mol Sci 2021; 22:11991. [PMID: 34769430 PMCID: PMC8584570 DOI: 10.3390/ijms222111991] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 11/03/2021] [Indexed: 12/12/2022] Open
Abstract
Topical and transdermal delivery systems are of undeniable significance and ubiquity in healthcare, to facilitate the delivery of active pharmaceutical ingredients, respectively, onto or across the skin to enter systemic circulation. From ancient ointments and potions to modern micro/nanotechnological devices, a variety of approaches has been explored over the ages to improve the skin permeation of diverse medicines and cosmetics. Amongst the latest investigational dermal permeation enhancers, ionic liquids have been gaining momentum, and recent years have been prolific in this regard. As such, this review offers an outline of current methods for enhancing percutaneous permeation, highlighting selected reports where ionic liquid-based approaches have been investigated for this purpose. Future perspectives on use of ionic liquids for topical delivery of bioactive peptides are also presented.
Collapse
Affiliation(s)
- Ana Gomes
- LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre 687, P-4169-007 Porto, Portugal; (A.G.); (L.A.); (R.F.); (C.T.)
| | - Luísa Aguiar
- LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre 687, P-4169-007 Porto, Portugal; (A.G.); (L.A.); (R.F.); (C.T.)
| | - Ricardo Ferraz
- LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre 687, P-4169-007 Porto, Portugal; (A.G.); (L.A.); (R.F.); (C.T.)
- Ciências Químicas e das Biomoléculas, CISA, Escola Superior de Saúde, Politécnico do Porto, R. Dr. António Bernardino de Almeida 400, P-4200-072 Porto, Portugal
| | - Cátia Teixeira
- LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre 687, P-4169-007 Porto, Portugal; (A.G.); (L.A.); (R.F.); (C.T.)
| | - Paula Gomes
- LAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre 687, P-4169-007 Porto, Portugal; (A.G.); (L.A.); (R.F.); (C.T.)
| |
Collapse
|